Abstract
The objective was to study the demographics, diagnostic procedures and therapies employed in order to provide guidelines to Emergency Department (ED) physicians. A six-month retrospective analysis of the records of all patients presenting with nontraumatic headache (NTH) to the EDs of the province of Trieste was performed. Of 38,238 patients screened, 300 (0.8%) presented with NTH and 49.7% were referred to specialists. Patients were classified as having secondary headache (41.3%), primary headache (24.3%) and headache with no obvious source (NOS) (34.4%). One hundred and seventy patients were treated with mono-or polytherapy. Of 50 patients with migraine, 36 were treated with NSAIDs and 4 with triptans. 68.4% of patients were referred to a general practitioner and 31.6% were admitted. The frequency of NTH was lower than in other studies. NOS headache was frequent. Only 10% of migraineurs received triptans. Diagnostic and therapeutic guidelines for ED physicians are needed.
for which thorough investigation and adequate treatment are mandatory; to screen the various forms of primary headaches and tailor therapeutic strategies; to know the efficacy of medical services in terms of admission to and discharge from hospital, follow-up, and assessment of individual and social costs.
The purpose of this study was to study the demographics, clinical characteristics, diagnostic procedures and therapies employed in patients presenting to the ED with a chief compliant of headache in order to provide diagnostic and therapeutic guidelines to ED physicians and improve the cost-to-benefit management of such patients.
Methods
A retrospective analysis of the records of all patients presenting in a six-month period (01.01.2004-30.06.2004) with NTH to the two EDs of the University Hospital of the province of Trieste was performed. The average annual ED number of visits is around 78,000. The study researchers selected from the ED records patients of both sexes over age 18 with a diagnosis of primary headache, secondary headache and headache of no obvious source (NOS), according to the International Classification of Headache Disorders 2nd edition [6] , whenever the presence of adequate information in the patient's record made it possible. Both EDs had homogeneous recording systems, therefore the selection of cases was done by electronic or manual means. For each patient demographic and clinical information, diagnostic tests and consulting visits ordered, therapies administered, time spent in ED, disposition and diagnosis at discharge were obtained. The data were processed and analysed using the Statistical Package for the Social Sciences (SPSS 11.0).
Results
Of 38,238 patients screened, 300 (0.8%) presented with NTH. Sixty-one percent were women and 39% men with a mean age of 45 (SD=19) years. Twenty-two patients had multiple admissions to the ED. One hundred and fortynine patients (49.7%) were referred to various specialists: in particular, 93 patients (31.1%) to the neurologist, 28 patients (9.3%) to other specialists and 28 (9.3%) to both the neurologist and other specialists. Neurological visits accounted for 81.2% of these specialist consultations and represented 12.7% of all neurological consulting visits to the ED in the same period. Twenty-one percent of patients underwent a CT of the skull. Seventy-three patients (24.3%) were classified as having primary headache, 124 (41.3%) secondary headache and 103 (34.4%) NOS headache. Figure 1 shows the frequency of the various forms of headache divided by the main chapters of IHS Classification, migraine being the most common headache (16.7%). Of the 103 patients with NOS headache, 41 (39.8%) received a specialist visit; among these, 36 (87.8%) were neurological visits. One hundred and seventy patients (56.6%) were treated with mono-or polytherapy (56.7% with NSAIDs, 13.4% with benzodiazepines, 10.7% with antiemetics, 6.2% with antihypertensives, 1.5% with triptans and 11.5% with other drugs). Of 50 patients with migraine, 40 received pharmacologic treatment, 90% with NSAIDs and 10% with triptans. The mean time spent in ED was 225 (SD=285) min, without differences between primary, secondary and NOS headaches. Taking into account the patients with migraine who have been treated, a significant difference in the length of stay in the ED between patients to whom triptans were administered (112 min, SD=25) and patients treated with 
